Studies in humans have demonstrated that C3, the most abundant component of the complement cascade, and its mediator molecules are increased in obesity, metabolic syndrome and cardiovascular disease [2], [5], [6], [7], [8], [9], [10]. This evidence concerns the gene C3 and metabolic syndrome.